JP2023554504A5 - - Google Patents
Info
- Publication number
- JP2023554504A5 JP2023554504A5 JP2023537585A JP2023537585A JP2023554504A5 JP 2023554504 A5 JP2023554504 A5 JP 2023554504A5 JP 2023537585 A JP2023537585 A JP 2023537585A JP 2023537585 A JP2023537585 A JP 2023537585A JP 2023554504 A5 JP2023554504 A5 JP 2023554504A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- protein
- composition according
- seq
- highly active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20214696 | 2020-12-16 | ||
| EP20214696.5 | 2020-12-16 | ||
| EP21209719 | 2021-11-22 | ||
| EP21209719.0 | 2021-11-22 | ||
| PCT/EP2021/086348 WO2022129438A1 (en) | 2020-12-16 | 2021-12-16 | Programmable transposases and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023554504A JP2023554504A (ja) | 2023-12-27 |
| JP2023554504A5 true JP2023554504A5 (enExample) | 2024-12-19 |
Family
ID=79287993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537585A Pending JP2023554504A (ja) | 2020-12-16 | 2021-12-16 | プログラム可能なトランスポザーゼおよびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240052371A1 (enExample) |
| EP (1) | EP4263819A1 (enExample) |
| JP (1) | JP2023554504A (enExample) |
| KR (1) | KR20230123492A (enExample) |
| AU (1) | AU2021403660A1 (enExample) |
| CA (1) | CA3202403A1 (enExample) |
| IL (1) | IL303612A (enExample) |
| MX (1) | MX2023007030A (enExample) |
| WO (1) | WO2022129438A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4114937A4 (en) | 2020-03-04 | 2024-09-04 | Flagship Pioneering Innovations VI, LLC | METHODS AND COMPOSITIONS FOR MODULATING A GENOME |
| KR20260037664A (ko) | 2021-09-08 | 2026-03-18 | 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 | 게놈을 조절하기 위한 방법 및 조성물 |
| AU2023269540A1 (en) | 2022-05-13 | 2024-11-07 | Integra Therapeutics | Use of transposases for improving transgene expression and nuclear localization |
| EP4709847A1 (en) * | 2023-05-10 | 2026-03-18 | Poseida Therapeutics, Inc. | Transposases and uses thereof |
| WO2024246338A2 (en) | 2023-06-01 | 2024-12-05 | Integra Therapeutics | Novel transposases and uses thereof |
| CN116813800B (zh) * | 2023-07-07 | 2024-03-12 | 南京诺唯赞生物科技股份有限公司 | 一种双链dna结合蛋白-转座酶融合蛋白及文库构建方法 |
| CN121586615A (zh) | 2023-09-15 | 2026-02-27 | 株式会社Lg化学 | 颗粒 |
| WO2026087488A1 (en) | 2024-10-21 | 2026-04-30 | Integra Therapeutics | Gene editing tools and compositions for cell engineering |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3277805B1 (en) * | 2015-03-31 | 2025-05-07 | SOHM, Inc. | Cas 9 retroviral integrase systems for targeted incorporation of a dna sequence into a genome of a cell |
| WO2018175872A1 (en) * | 2017-03-24 | 2018-09-27 | President And Fellows Of Harvard College | Methods of genome engineering by nuclease-transposase fusion proteins |
| AU2020290790B2 (en) | 2019-06-11 | 2026-02-19 | Universitat Pompeu Fabra | Targeted gene editing constructs and methods of using the same |
-
2021
- 2021-12-16 JP JP2023537585A patent/JP2023554504A/ja active Pending
- 2021-12-16 MX MX2023007030A patent/MX2023007030A/es unknown
- 2021-12-16 US US18/258,039 patent/US20240052371A1/en active Pending
- 2021-12-16 AU AU2021403660A patent/AU2021403660A1/en active Pending
- 2021-12-16 IL IL303612A patent/IL303612A/en unknown
- 2021-12-16 WO PCT/EP2021/086348 patent/WO2022129438A1/en not_active Ceased
- 2021-12-16 CA CA3202403A patent/CA3202403A1/en active Pending
- 2021-12-16 KR KR1020237023944A patent/KR20230123492A/ko active Pending
- 2021-12-16 EP EP21839989.7A patent/EP4263819A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12173284B2 (en) | Modified guide RNAs | |
| JP7094323B2 (ja) | 最適化機能ＣＲＩＳＰＲ－Ｃａｓ系による配列操作のための系、方法および組成物 | |
| JP7093728B2 (ja) | 化学的に修飾されたガイドｒｎａを使用する高特異性ゲノム編集 | |
| AU2014361834B2 (en) | CRISPR-Cas systems and methods for altering expression of gene products, structural information and inducible modular Cas enzymes | |
| JP2025181841A5 (enExample) | ||
| US12509492B2 (en) | Genome engineering with CRISPR-Cas systems in eukaryotes | |
| EP3433362B1 (en) | Methods for enhancing the efficiency of gene editing | |
| JP2024502348A (ja) | Ｔｒａｃｒ不含 Ｖ型Ｃａｓシステム用のガイドＲＮＡデザインおよび複合体 | |
| US20230212615A1 (en) | Grna targeting ctgf gene and use thereof | |
| KR20220112698A (ko) | 교정 효율이 개선된 프라임에디팅용 조성물 | |
| Li et al. | Site-directed RNA editing by harnessing ADARs: advances and challenges | |
| JP2022188178A (ja) | Ｍａｓｔ４遺伝子を利用した細胞外基質生産用組成物及びその製造方法 | |
| CN117959446A (zh) | miR-103-3p在调控鸡卵泡发育中的应用 | |
| US20250283036A1 (en) | Engineering b cell-based protein factories to treat serious diseases | |
| JP2020513849A5 (enExample) | ||
| US20240309347A1 (en) | Fusion Proteins for CRISPR-based Transcriptional Repression | |
| JP2025518638A5 (enExample) | ||
| WO2025080959A1 (en) | Compositions and methods for treating pulmonary arterial hypertension | |
| JP2025518638A (ja) | 導入遺伝子の発現および核局在化を改善するためのトランスポザーゼの使用 | |
| Halmai | Epigenetic Editing of the X-Linked Intellectual Disability Genes CDKL5 and MECP2 | |
| HK40107754A (zh) | 工程改造基於b细胞的蛋白质工厂以治疗严重疾病 | |
| JP2023031025A (ja) | 小胞分泌制御剤および小胞取り込み制御剤 |